Multi-drug anti-angiogenic (anti-VEGF) therapy with a regimen consisting of five drugs has also been found to be beneficial as an adjuvant to re-irradiation for recurrent medulloblastoma [28]. This evidence concerns the gene VEGFA and medulloblastoma.